UC study: Protein helps prevent breast cancer metastasis
Novel findings of systematic study published in Cell Reports
While better screening and improved treatments are leading to better outcomes for patients with breast cancer, 90% of breast cancer deaths are a result of metastasis, or the cancer growing and spreading to other parts of the body.
University of Cincinnati Cancer Center researchers in the lab of Jun-Lin Guan, PhD, have identified a new protein that helps prevent metastasis of a subset called HER2-positive breast cancer. About 20% of patients have HER2-positive breast cancer, and these cancers tend to be more aggressive than other types.
The study findings were recently published in the journal Cell Reports.
Study background
Guan’s lab has focused on how autophagy, or the cell's “recycling” function, affects cancer metastasis.
“Autophagy can be likened to a self-cleansing mechanism within cells,” said Mingang Hao, PhD, first author of the study and research scientist in Guan’s lab. “It allows them to eliminate undesirable or harmful components and emerge stronger and unharmed. In the context of cancer, dysfunctional autophagy has been linked to the development and progression of tumors.”
Research published in 2021 led by Hao found that blocking autophagy in HER2-positive breast cancer cells helped eliminate cancer development in an animal model of the disease. However, it was not clear whether the autophagy blockade also inhibited the process of cancer metastasis, as the lack of metastasis could be due to the elimination of the primary tumor growth in the model.
Very few studies in the field have directly examined the role of autophagy in metastasis, and most studies focused on genes thought to only play a role in autophagy (so-called “core” autophagy genes).
“In addition to these primary autophagy genes, which have been a major focus of research on cancer development and progression, there are many other proteins which regulate autophagy within cells,” Hao said.
I view this as one of the most important findings from my lab and a culmination of a lot of research expertise.
Jun-Lin Guan, PhD
Study results
Using CRISPR gene-editing technology, Hao and his colleagues created a specialized genetic library that targeted 171 different genes that are involved in autophagy regulation. By “turning off” each gene, the researchers aimed to identify specific genes that prevented the spread of breast cancer cells.
Using this technique, Hao said they identified a protein called p47 that prevents breast cancer metastasis.
“It does this by affecting different cellular pathways that are crucial for tumor cell movement,” Hao said. “These findings help us better understand the mechanisms behind cancer metastasis and may eventually lead to new strategies for preventing or treating the spread of breast cancer.”
In human breast cancer samples, lower p47 expression was correlated with higher breast cancer metastasis.
“This is one of the first few studies that links a particular autophagy regulatory gene with cancer metastasis with clear mechanisms that can potentially lead to the development of new therapies,” said Guan, professor and former chair of the Department of Cancer Biology in UC’s College of Medicine. “I view this as one of the most important findings from my lab and a culmination of a lot of research expertise as well as unique reagents we generated over the years.”
Guan said cancer drugs are often developed to inhibit a gene that helps cancer cells grow, but in the case of p47, a potential therapy would seek to increase the functions of the protein so that it can prevent metastasis.
“I would argue it’s more powerful than inhibiting something,” he said, noting popular immunotherapy drug pembrolizumab similarly works by boosting a pathway the body uses to fight cancer.
Moving forward, the research team will seek to learn more about p47’s mechanism of action and potential to be developed as a therapeutic. The researchers identified additional genes involved in autophagy that appear to affect metastasis that could become further targets for new treatments.
The gene library Hao custom-developed for this study is also available for other researchers at the Cancer Center and other institutions to use to identify potential targets in other cancers.
Hao began this particular line of research in 2018 and said patience, time, effort and genuine interest in your work are essential for cancer researchers.
Guan said many researchers focus on one protein or gene at a time, but it takes a specific expertise to conduct systematic, impactful research of many genes at one time.
“Mingang’s previous work laid the foundation for this, so this is something very unique that not many labs would be able to perform,” Guan said. “When I recruited him, this was the kind of thing I hoped he could do.”
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Featured photo of 3D breast cancer cell courtesy of the National Cancer Institute.
This research was funded by the National Institutes of Health (R01 CA211066; R01 HL073394; R01 NS094144). Researchers cite no conflicts of interest.
Related Stories
Bono, Chris Tucker Visit UC To Discuss Africa
December 5, 2002
U2's Bono and comedian-actor Chris Tucker led a delegation from the DATA organization who came to UC to talk about potentially catastrophic problems in Africa.
New Year's Help for Those Looking to Kick the Habit
December 20, 2002
Quitting smoking consistently ranks among the top three resolutions made by New Year's resolvers each year.
E-BRIEF: Let's Toast to a Healthier 2003
January 8, 2003
The New Year often means a new health kick: Vows to tone up and trim down, and maybe going to the doctor and getting ourselves as regularly "maintenanced" as we do our cars. So, this week's University of Cincinnati e-briefing examines the health concerns of the young and old, and what you should be doing to preserve your good health.
Today's ML King Events: One On, One Off
January 8, 2003
A memorial march, presentations, poetry and dance will pay tribute to the slain civil rights leader.
UC Named Lead Organization for OSHA Training Consortium
January 13, 2003
UC Continuing Medical Education (CME) has been selected as the lead organization for the Occupational Safety and Health Administration (OSHA) Great Lakes Training Consortium by the U.S. Department of Labor.
Ignorance of Stroke s Warning Signs a Barrier to Treatment; More Education Needed, UC Researchers Report in JAMA
January 13, 2003
Demographic groups facing the greatest risk of death and disability from stroke are the least likely to recognize stroke s warning signs and risk factors, according to a study by UC researchers published in the January 15 issue of the Journal of the American Medical Association (JAMA).
Ignorance of Stroke s Warning Signs a Barrier to Treatment; More Education Needed, UC Researchers Report in JAMA
January 14, 2003
Demographic groups facing the greatest risk of death and disability from stroke are the least likely to recognize stroke s warning signs and risk factors, according to a study by UC researchers published in the January 15 issue of the Journal of the American Medical Association (JAMA).
UC Researchers Find New Link Between the Eye and the Clock in the Brain
January 20, 2003
Results of a study done by a team of researchers working in the laboratories of Michael Lehman, PhD, professor, Department of Cell Biology, Neurobiology, and Anatomy at the UC College of Medicine, will appear in the February issue of Nature Neuroscience.
UC Researchers Find New Link Between the Eye and the Clock in the Brain
January 21, 2003
Results of a study done by a team of researchers working in the laboratories of Michael Lehman, PhD, professor, Department of Cell Biology, Neurobiology, and Anatomy at the UC College of Medicine, will appear in the February issue of Nature Neuroscience.
Leader of Fetal Surgery to Deliver Lectures at UC
January 31, 2003
An internationally recognized authority on fetal surgery will lecture at the UC Medical Center, representing the first of a series of lectures on fetal surgery presented by the department of Obstetrics and Gynecology (Ob/Gyn).